IOL Advances

One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S.

Phakic option provides hope to patients who are not candidates for laser vision correction.

To mark the 20th anniversary of its TECNIS IOLs, Johnson & Johnson Vision is launching the “See More” campaign to educate patients and physicians on what is possible with cataract surgery.

Daniel H. Chang, MD, shares data on a recent study involving a new violet light-filtering chromophore in a preclinical computer simulation testing and randomized clinical study.

Phakic lenses are proving to be excellent additions to refractive practices.

Procedure increases lens stability and improves visual acuity in patients.

Optics block out-of-focus and stray light, allow continuum of vision.

Benefits of intracameral phenylephrine/ketorolac continue to add up.

Monofocal toric lens delivers effective astigmatic correction and more, study results show

RLE, in unexpected twist, is gaining support among surgeons

Investigators find value in screening for macular disease in preoperative evaluation

Checking own work postoperatively offers value to ophthalmologists

No matter the technology used, it is necessary to customize the implant choice based on the patient’s needs to achieve optimal refractive outcomes.

Researchers are looking for options to reduce corneal surface flora in patients

Just as evolving technology is changing patients' visual demands, eye-care providers should increase their awareness and efforts to fill current gaps.

Patient expectations continue to push clinicians to look at optimal ways to arrive at the best IOLs.